Boris Peaker
Stock Analyst at TD Cowen
(1.82)
# 3,060
Out of 4,736 analysts
22
Total ratings
33.33%
Success rate
5.49%
Average return
Main Sectors:
Stocks Rated by Boris Peaker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AADI Aadi Bioscience | Downgrades: Hold | n/a | $3.02 | - | 2 | Aug 21, 2024 | |
| GLYC GlycoMimetics | Downgrades: Hold | n/a | $0.26 | - | 1 | Jul 26, 2024 | |
| MGNX MacroGenics | Downgrades: Hold | n/a | $3.00 | - | 3 | May 10, 2024 | |
| LNTH Lantheus Holdings | Initiates: Outperform | $100 | $94.05 | +6.33% | 1 | Dec 4, 2023 | |
| ADCT ADC Therapeutics | Downgrades: Market Perform | n/a | $1.76 | - | 1 | Nov 9, 2023 | |
| PCRX Pacira BioSciences | Upgrades: Outperform | $50 | $22.84 | +118.91% | 1 | Aug 3, 2023 | |
| PCVX Vaxcyte | Initiates: Outperform | n/a | $88.17 | - | 1 | Apr 18, 2023 | |
| XNCR Xencor | Initiates: Outperform | n/a | $20.45 | - | 1 | Dec 6, 2022 | |
| EBS Emergent BioSolutions | Maintains: Market Perform | $30 → $29 | $10.22 | +183.76% | 1 | Sep 12, 2022 | |
| CTMX CytomX Therapeutics | Downgrades: Market Perform | n/a | $0.87 | - | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $95 → $102 | $96.24 | +5.99% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.90 | - | 1 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.15 | - | 1 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.37 | - | 1 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $11.21 | - | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.99 | - | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $0.55 | - | 1 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $647.39 | - | 1 | Jun 12, 2017 |
Aadi Bioscience
Aug 21, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.02
Upside: -
GlycoMimetics
Jul 26, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.26
Upside: -
MacroGenics
May 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.00
Upside: -
Lantheus Holdings
Dec 4, 2023
Initiates: Outperform
Price Target: $100
Current: $94.05
Upside: +6.33%
ADC Therapeutics
Nov 9, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.76
Upside: -
Pacira BioSciences
Aug 3, 2023
Upgrades: Outperform
Price Target: $50
Current: $22.84
Upside: +118.91%
Vaxcyte
Apr 18, 2023
Initiates: Outperform
Price Target: n/a
Current: $88.17
Upside: -
Xencor
Dec 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $20.45
Upside: -
Emergent BioSolutions
Sep 12, 2022
Maintains: Market Perform
Price Target: $30 → $29
Current: $10.22
Upside: +183.76%
CytomX Therapeutics
Jul 11, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $0.87
Upside: -
Jun 27, 2022
Maintains: Market Perform
Price Target: $95 → $102
Current: $96.24
Upside: +5.99%
Mar 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $0.90
Upside: -
Mar 3, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.15
Upside: -
Aug 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.37
Upside: -
Jul 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $11.21
Upside: -
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $1.99
Upside: -
Jul 24, 2017
Initiates: Outperform
Price Target: n/a
Current: $0.55
Upside: -
Jun 12, 2017
Initiates: Outperform
Price Target: n/a
Current: $647.39
Upside: -